EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Stimuli-activatable protein degraders for targeted cancer therapy: from prodrug design to nanoplatform applications

Xingyu Jiang, Yinuo Chen, Yunna Gao, Rui Rong, Yi Lai, Zheying Zhu, Zhiai Xu

Advanced Drug Delivery Reviews · 2026-05 · 232 · 115808

DOI: 10.1016/j.addr.2026.115808 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-05. Verfasst von Xingyu Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200241, China. Hauptthemen laut MEDLINE: Prodrugs, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 239 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsNeoplasmsAntineoplastic AgentsHumansProteolysis Targeting ChimeraAnimalsDrug DesignProteolysisDrug Delivery Systems

Stichwörter der Autor:innen

Cancer therapyPROTAC prodrugPrecision therapyProtein degradationStimuli activation

Substanzen

ProdrugsProteolysis Targeting ChimeraAntineoplastic Agents

Autor:innen und Institutionen

  • School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200241, China.
  • Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Division of Molecular Therapeutics & Formulation, School of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK.
  • School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200241, China. Electronic address: zaxu@chem.ecnu.edu.cn.

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Jiang, X., Chen, Y., Gao, Y., Rong, R., Lai, Y., Zhu, Z., & Xu, Z. (2026). Stimuli-activatable protein degraders for targeted cancer therapy: from prodrug design to nanoplatform applications. Advanced Drug Delivery Reviews, 232, 115808. https://doi.org/10.1016/j.addr.2026.115808

Vancouver

Jiang X, Chen Y, Gao Y, Rong R, Lai Y, Zhu Z, et al. Stimuli-activatable protein degraders for targeted cancer therapy: from prodrug design to nanoplatform applications. Advanced Drug Delivery Reviews. 2026;232:115808. doi:10.1016/j.addr.2026.115808

BibTeX
@article{Jiang2026,
  author = {Jiang, Xingyu and Chen, Yinuo and Gao, Yunna and Rong, Rui and Lai, Yi and Zhu, Zheying and Xu, Zhiai},
  title = {Stimuli-activatable protein degraders for targeted cancer therapy: from prodrug design to nanoplatform applications},
  journal = {Advanced Drug Delivery Reviews},
  year = {2026},
  volume = {232},
  pages = {115808},
  doi = {10.1016/j.addr.2026.115808}
}
Kostenlos starten →